NewslettersHepatic Cell NewsUncategorizedGalectin-1 Confers Resistance to Doxorubicin in Hepatocellular Carcinoma Cells through Modulation of P-glycoprotein ExpressionBy Justin.choi - January 25, 202208Researchers investigated the molecular mechanism underlying galectin-1-mediated chemoresistance in hepatocellular carcinoma cells, particularly the involvement of P-glycoprotein in this effect.[Cell Death & Disease] 7992332 {7992332:BBBBBBBB} apa 50 1 171112 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article